Yale's AZA Allsop, MD, PhD, on psychedelics as medicine versus wellness tools, and why naturalistic research settings matter for the field.
AZA Allsop, MD, PhD
Advertisement
Articles by AZA Allsop, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2
2
Do GLP-1 Receptor Agonists Increase the Risk of Smell and Taste Disturbances?
3
FDA Scrutiny of GLP-1 Compounding Is Just Getting Started, Expert Says
4
FDA Approves Risankizumab for Pediatric Plaque Psoriasis, Psoriatic Arthritis
5